What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in your body. It plays an essential role in mitochondrial energy production, DNA repair, and cellular resilience.
As NAD+ levels decline with age, people may experience fatigue, slower recovery, reduced mental clarity, and decreased stress tolerance.
Why NAD+ Levels Decline
NAD+ levels naturally decrease due to:
- Aging
- Chronic stress and poor sleep
- Poor diet or high-sugar intake
- Alcohol or smoking
- Certain medications and medical conditions
What is NAD+ Therapy?
NAD+ therapy refers to medically supervised protocols designed to support or replenish NAD+ levels. At He-MD, therapy may include:
- Rx NAD+ injectables
- Rx NAD+ nasal spray when clinically appropriate
These approaches may offer more consistent delivery than over-the-counter supplements.
Learn more about NAD+ therapy at He-MD here:
https://heandshemd.com/longevity/nad-injectable.
Potential Benefits Patients Ask About
- Energy and stamina
- Cognitive function, focus, and clarity
- Post-workout recovery
- Healthy aging and cellular support
How NAD+ Therapy Works at He-MD
- Online intake through a secure, mobile-friendly form
- Licensed provider review of symptoms and medical history
- Personalized protocol based on your goals
- Home delivery from a licensed partner pharmacy
- Follow-up support from your provider
Is NAD+ Therapy Right For You?
NAD+ therapy may be appropriate for individuals seeking to support:
- Cellular health and longevity
- Energy and productivity
- Recovery from training
- Healthy aging
Side Effects & Safety
Possible side effects may include:
- Mild headache
- Nausea
- Flushing or warmth
- Local irritation from injections
The Bottom Line
NAD+ is essential for cellular energy and repair. For individuals focused on longevity, recovery, and overall vitality,
medically supervised NAD+ therapy can be a valuable addition to a comprehensive wellness plan.
Learn more about He-MD’s NAD+ treatment options:
https://heandshemd.com/longevity/nad-injectable